Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VRAX
VRAX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VRAX News
Virax Biolabs Reports Positive Early Data for ViraxImmune™ Test
May 26 2026
PRnewswire
Virax Biolabs Reports Positive Early Data for ViraxImmune™ Test
May 26 2026
Newsfilter
Virax Biolabs Advances U.S. Market Strategy with ViraxImmune™
Apr 14 2026
PRnewswire
Virax Biolabs Advances U.S. Market Strategy with ViraxImmune™
Apr 14 2026
Newsfilter
Virax Biolabs Achieves ISO Certifications for Quality Management
Mar 31 2026
PRnewswire
Virax Biolabs Achieves ISO 13485 and ISO 9001 Certifications
Mar 31 2026
Newsfilter
Virax Biolabs Closes $5 Million Private Placement to Extend Cash Runway
Dec 04 2025
PRnewswire
Virax Biolabs Secures $5 Million Funding to Extend Cash Runway into 2028
Dec 04 2025
Newsfilter
UiPath Shares Rise Approximately 9%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 04 2025
Benzinga
Virax Biolabs Announces $5 Million Private Placement Deal
Dec 04 2025
NASDAQ.COM
Virax Biolabs (VRAX) Shares Decline in After-Hours Trading After 75% Surge
Dec 04 2025
Benzinga
Virax Biolabs Secures $5 Million in Private Placement for 12.5 Million Shares
Dec 03 2025
PRnewswire
Virax Biolabs Secures $5 Million by Issuing 12.5 Million Shares at $0.40 Each
Dec 03 2025
Newsfilter
US Stocks Show Varied Performance; Dollar Tree Reports Positive Earnings
Dec 03 2025
Benzinga
Virax Biolabs Advances PAIS Diagnostic Technology, Data Release Expected in 2026
Dec 03 2025
PRnewswire
EXCLUSIVE: Virax Biolabs Signs Research Agreement to Enhance Long COVID Diagnostic Research
Aug 26 2025
Yahoo Finance
Show More News
